Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sommer

Showing results (251-260 of 279) with videos related to

Pageof 28
Sort By:
Neuroimage|April 5, 2021
Functional parcellation of human and macaque striatum reveals human-specific connectivity in the dorsal caudateXiaojin Liu, Simon B Eickhoff, Svenja Caspers, et al.
Molecular Psychiatry|June 9, 2018
Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre <sup>1</sup>H-MRS study (OPTiMiSE)A Egerton, B V Broberg, N Van Haren, et al.
Journal of Pediatric Urology|February 21, 2026
Peak systolic velocity, not vein size, predicts abnormal sperm count in adolescent Tanner V patients with primary left varicoceleDiego R Álvarez Vega, Jordan Mendelson, Joseph M Pizzuti, et al.
Schizophrenia Bulletin|July 12, 2022
Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled TrialsOndine Adam, Martin Blay, Andre R Brunoni, et al.
Schizophrenia Bulletin|February 20, 2021
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled TrialIris E Sommer, Shiral S Gangadin, Lot D de Witte, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 17, 2026
Intrinsic connectivity patterns of striatal subfields predict individual dimensions of psychopathology and are associated with cholinergic and serotonergic neurotransmission in schizophreniaZhiqiu He, Wenli He, Zhiyi Chen, et al.
British Journal of Pharmacology|February 2, 2022
Community guidelines for GPCR ligand bias: IUPHAR review 32Peter Kolb, Terry Kenakin, Stephen P H Alexander, et al.
The Lancet. Psychiatry|August 18, 2018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching studyRené S Kahn, Inge Winter van Rossum, Stefan Leucht, et al.
BMJ Public Health|August 5, 2025
What all physicians should know about women's health: a Delphi studyMerel H de Heer-Koster, Chiara Benedetto, Vesna Bjegović-Mikanović, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 22, 2020
Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapineElias Wagner, William G Honer, Iris E Sommer, et al.
Pageof 28

Showing results (251-260 of 279) with videos related to

Sort By:
Pageof 28
Neuroimage|April 5, 2021
Functional parcellation of human and macaque striatum reveals human-specific connectivity in the dorsal caudateXiaojin Liu, Simon B Eickhoff, Svenja Caspers, et al.
Molecular Psychiatry|June 9, 2018
Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre <sup>1</sup>H-MRS study (OPTiMiSE)A Egerton, B V Broberg, N Van Haren, et al.
Journal of Pediatric Urology|February 21, 2026
Peak systolic velocity, not vein size, predicts abnormal sperm count in adolescent Tanner V patients with primary left varicoceleDiego R Álvarez Vega, Jordan Mendelson, Joseph M Pizzuti, et al.
Schizophrenia Bulletin|July 12, 2022
Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled TrialsOndine Adam, Martin Blay, Andre R Brunoni, et al.
Schizophrenia Bulletin|February 20, 2021
Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled TrialIris E Sommer, Shiral S Gangadin, Lot D de Witte, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 17, 2026
Intrinsic connectivity patterns of striatal subfields predict individual dimensions of psychopathology and are associated with cholinergic and serotonergic neurotransmission in schizophreniaZhiqiu He, Wenli He, Zhiyi Chen, et al.
British Journal of Pharmacology|February 2, 2022
Community guidelines for GPCR ligand bias: IUPHAR review 32Peter Kolb, Terry Kenakin, Stephen P H Alexander, et al.
The Lancet. Psychiatry|August 18, 2018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching studyRené S Kahn, Inge Winter van Rossum, Stefan Leucht, et al.
BMJ Public Health|August 5, 2025
What all physicians should know about women's health: a Delphi studyMerel H de Heer-Koster, Chiara Benedetto, Vesna Bjegović-Mikanović, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 22, 2020
Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapineElias Wagner, William G Honer, Iris E Sommer, et al.
Pageof 28